US8523123052
US8523123052
STAAR Surgical Company
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.09B EUR | 1.44B EUR | 930.89M EUR | 1.14B EUR |
Enterprise Value | 976.67M EUR | 1.33B EUR | 836.31M EUR | 1.03B EUR |
Valuation Multiples | ||||
Trailing P/E | 270.88x | 374.58x | -- | -- |
Forward P/E | 19.5x | -- | -- | -- |
Price to Sales | 3.2x | 4.23x | 3.21x | 5.79x |
Price to Book | 2.97x | 3.94x | 2.64x | 3.31x |
EV/Revenue | 2.88x | 3.9x | 2.88x | 5.21x |
EV/EBITDA | 19.63x | 16.37x | 17.72x | 60.18x |
Price to FCF (P/FCF) | 70.8x | -- | -- | -- |
EV/FCF | 63.63x | -- | -- | -- |
FCF Yield | 1.41% | -0.47% | -5.91% | -2.88% |